+关注
范毅
暂无个人介绍
IP属地：江苏
3
关注
0
粉丝
0
主题
0
勋章
主贴
热门
范毅
10-28
说说你对这篇新闻的看法...
异动解读｜Recursion Pharmaceuticals, Inc.盘中上涨8.02%，公司预告将披露REC-4881更新数据
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4205841862046452","uuid":"4205841862046452","gmtCreate":1742738681449,"gmtModify":1764945501329,"name":"范毅","pinyin":"fyfanyi","introduction":"","introductionEn":null,"signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":3,"tweetSize":1,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.08.06","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"江苏","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":623237803517136,"gmtCreate":1793197211723,"gmtModify":1793197253854,"author":{"id":"4205841862046452","authorId":"4205841862046452","name":"范毅","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205841862046452","authorIdStr":"4205841862046452"},"themes":[],"title":"","htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/623237803517136","repostId":"1180706087","repostType":2,"repost":{"id":"1180706087","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"行情直击","id":"1059448697","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"pubTimestamp":1793197104,"share":"https://www.laohunote.com/m/news/1180706087?lang=zh_CN&edition=full","pubTime":"2026-10-28 22:18","market":"us","language":"zh","title":"异动解读｜Recursion Pharmaceuticals, Inc.盘中上涨8.02%，公司预告将披露REC-4881更新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1180706087","media":"行情直击","summary":"10月28日，Recursion Pharmaceuticals, Inc.盘中上涨8.02%，报4.375美元/股，成交额2460.47万美元。消息面上，公司宣布将于11月3日举行网络研讨会，聚焦CGA-IGC更新披露REC-4881数据，并包含业绩更新、关键意见领袖及患者讨论环节，成为股价异动的直接催化。此外，公司此前还披露，赛诺菲已选择双方合作中的首个候选药物，触发1000万美元里程碑付款；该合作累计预付款及里程碑付款已达1.44亿美元，后续仍有超3亿美元潜在里程碑及双位数销售分成空间。","content":"<p><p>10月28日，Recursion Pharmaceuticals, Inc.盘中上涨8.02%，报4.375美元/股，成交额2460.47万美元。</p><p>消息面上，公司宣布将于11月3日举行网络研讨会，聚焦CGA-IGC更新披露REC-4881（FAP）数据，并包含业绩更新、关键意见领袖及患者讨论环节，成为股价异动的直接催化。</p><p>此外，公司此前还披露，赛诺菲已选择双方合作中的首个候选药物，触发1000万美元里程碑付款；该合作累计预付款及里程碑付款已达1.44亿美元，后续仍有超3亿美元潜在里程碑及双位数销售分成空间。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读｜Recursion Pharmaceuticals, Inc.盘中上涨8.02%，公司预告将披露REC-4881更新数据</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读｜Recursion Pharmaceuticals, Inc.盘中上涨8.02%，公司预告将披露REC-4881更新数据\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1059448697\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">行情直击 </p>\n<p class=\"h-time\">2026-10-28 22:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>10月28日，Recursion Pharmaceuticals, Inc.盘中上涨8.02%，报4.375美元/股，成交额2460.47万美元。</p><p>消息面上，公司宣布将于11月3日举行网络研讨会，聚焦CGA-IGC更新披露REC-4881（FAP）数据，并包含业绩更新、关键意见领袖及患者讨论环节，成为股价异动的直接催化。</p><p>此外，公司此前还披露，赛诺菲已选择双方合作中的首个候选药物，触发1000万美元里程碑付款；该合作累计预付款及里程碑付款已达1.44亿美元，后续仍有超3亿美元潜在里程碑及双位数销售分成空间。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RXRX":"Recursion Pharmaceuticals, Inc."},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180706087","content_text":"10月28日，Recursion Pharmaceuticals, Inc.盘中上涨8.02%，报4.375美元/股，成交额2460.47万美元。消息面上，公司宣布将于11月3日举行网络研讨会，聚焦CGA-IGC更新披露REC-4881（FAP）数据，并包含业绩更新、关键意见领袖及患者讨论环节，成为股价异动的直接催化。此外，公司此前还披露，赛诺菲已选择双方合作中的首个候选药物，触发1000万美元里程碑付款；该合作累计预付款及里程碑付款已达1.44亿美元，后续仍有超3亿美元潜在里程碑及双位数销售分成空间。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","news_type":1,"symbols_score_info":{"RXRX":1}},"isVote":1,"tweetType":1,"viewCount":22,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":623237803517136,"gmtCreate":1793197211723,"gmtModify":1793197253854,"author":{"id":"4205841862046452","authorId":"4205841862046452","name":"范毅","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4205841862046452","authorIdStr":"4205841862046452"},"themes":[],"title":"","htmlText":"说说你对这篇新闻的看法...","listText":"说说你对这篇新闻的看法...","text":"说说你对这篇新闻的看法...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/623237803517136","repostId":"1180706087","repostType":2,"repost":{"id":"1180706087","kind":"news","weMediaInfo":{"introduction":"个股异动一手消息解读","home_visible":1,"media_name":"行情直击","id":"1059448697","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"pubTimestamp":1793197104,"share":"https://www.laohunote.com/m/news/1180706087?lang=zh_CN&edition=full","pubTime":"2026-10-28 22:18","market":"us","language":"zh","title":"异动解读｜Recursion Pharmaceuticals, Inc.盘中上涨8.02%，公司预告将披露REC-4881更新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1180706087","media":"行情直击","summary":"10月28日，Recursion Pharmaceuticals, Inc.盘中上涨8.02%，报4.375美元/股，成交额2460.47万美元。消息面上，公司宣布将于11月3日举行网络研讨会，聚焦CGA-IGC更新披露REC-4881数据，并包含业绩更新、关键意见领袖及患者讨论环节，成为股价异动的直接催化。此外，公司此前还披露，赛诺菲已选择双方合作中的首个候选药物，触发1000万美元里程碑付款；该合作累计预付款及里程碑付款已达1.44亿美元，后续仍有超3亿美元潜在里程碑及双位数销售分成空间。","content":"<p><p>10月28日，Recursion Pharmaceuticals, Inc.盘中上涨8.02%，报4.375美元/股，成交额2460.47万美元。</p><p>消息面上，公司宣布将于11月3日举行网络研讨会，聚焦CGA-IGC更新披露REC-4881（FAP）数据，并包含业绩更新、关键意见领袖及患者讨论环节，成为股价异动的直接催化。</p><p>此外，公司此前还披露，赛诺菲已选择双方合作中的首个候选药物，触发1000万美元里程碑付款；该合作累计预付款及里程碑付款已达1.44亿美元，后续仍有超3亿美元潜在里程碑及双位数销售分成空间。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>异动解读｜Recursion Pharmaceuticals, Inc.盘中上涨8.02%，公司预告将披露REC-4881更新数据</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n异动解读｜Recursion Pharmaceuticals, Inc.盘中上涨8.02%，公司预告将披露REC-4881更新数据\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1059448697\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">行情直击 </p>\n<p class=\"h-time\">2026-10-28 22:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>10月28日，Recursion Pharmaceuticals, Inc.盘中上涨8.02%，报4.375美元/股，成交额2460.47万美元。</p><p>消息面上，公司宣布将于11月3日举行网络研讨会，聚焦CGA-IGC更新披露REC-4881（FAP）数据，并包含业绩更新、关键意见领袖及患者讨论环节，成为股价异动的直接催化。</p><p>此外，公司此前还披露，赛诺菲已选择双方合作中的首个候选药物，触发1000万美元里程碑付款；该合作累计预付款及里程碑付款已达1.44亿美元，后续仍有超3亿美元潜在里程碑及双位数销售分成空间。</p><p>（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RXRX":"Recursion Pharmaceuticals, Inc."},"source_url":"","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1180706087","content_text":"10月28日，Recursion Pharmaceuticals, Inc.盘中上涨8.02%，报4.375美元/股，成交额2460.47万美元。消息面上，公司宣布将于11月3日举行网络研讨会，聚焦CGA-IGC更新披露REC-4881（FAP）数据，并包含业绩更新、关键意见领袖及患者讨论环节，成为股价异动的直接催化。此外，公司此前还披露，赛诺菲已选择双方合作中的首个候选药物，触发1000万美元里程碑付款；该合作累计预付款及里程碑付款已达1.44亿美元，后续仍有超3亿美元潜在里程碑及双位数销售分成空间。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）","news_type":1,"symbols_score_info":{"RXRX":1}},"isVote":1,"tweetType":1,"viewCount":22,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}
